ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We entered the quarter with a great deal of momentum having achieved a key validating development milestone for our platform asset evorpacept in Q4 2023 by repo...
MeiraGTx Reports First Quarter 2024 Financial and Operational Results - Positive data from the Phase 1 AQUAx study in radiation-induced xerostomia (RIX) presented in an oral session at the American Academy of Oral Medicine 2024 annual meeting (AAOM) April 17-20, 2024 - Received $50 million milestone following initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) - Clinical development milestones met and remain on track for the rest of the year for AAV-hA...
Zscaler to Host Third Quarter Fiscal Year 2024 Earnings Conference Call Earnings Results to be Released on Thursday, May 30, After the Close of the Market SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release third quarter fiscal year 2024 earnings after the market closes on Thursday, May 30, 2024. The company will host an investor conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss the results. Date:Thursday, May 30th, 2024Time:1:30 p.m. PTWebcast:Dial-in:To join by phone, register at...
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights Continued Enrollment in Global Phase 3 CoMpass Trial in Small Choroidal Melanoma and Indeterminate Lesions Ongoing Phase 1 Trial in Bladder Cancer Enrolling; Early Data Expected Mid-2024 Strong Cash Position Expected to Fund Operations into Second Half of 2026 BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today reported financial res...
Two Directors at Wayfair Inc sold 20,000 shares at between 68.033USD and 68.259USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Magnite Reports First Quarter 2024 Results Total Revenue Grows 15% & Contribution ex-TAC(1) Grows 12% Year-Over-Year Contribution ex-TAC(1) from CTV Grows 18% Year-Over-Year NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the world's largest independent sell-side advertising company, today reported its results of operations for the quarter ended March 31, 2024. Q1 2024 Highlights: Revenue of $149.3 million, up 15% year-over-yearContribution ex-TAC(1) of $130.6 million, up 12% year-over-yearContribution ex-TAC(1) attributable to CTV of $54.9 million, up 18% year-over...
Aura Biosciences to Participate in Upcoming Investor Conferences BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences: The Citizens JMP Life Sciences Conference on Monday, May 13, 2024.Fireside Chat at 9:00 a.m. ET. TD Cowen 5th Annual Oncology Innovation Summit on Wedn...
Norwegian Cruise Line Holdings to Host 2024 Investor Day MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) announced today it will host its 2024 Investor Day on May 20th at 9am ET in New York at the New York Stock Exchange. The event will feature presentations and a question-and-answer session with Harry Sommer, president and chief executive officer, and other members of the Company’s senior leadership team. Attendance at the live event is by...
ALX Oncology Appoints Allison Dillon as Chief Business Officer SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer (“CBO”). “We are excited to welcome Allison to our leadership team in the midst of this promising growth period for our Company,” said Jason Lettmann, Chief Executive Officer of ALX Oncology. “For over 15 yea...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data and Threat Protection Enterprises can now Ensure Secure, Remote Access to Private Web Apps across devices and locations with Zscaler and Google Chrome Enterprise SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ZS), the leader in cloud security, has collaborated with Google on a joint zero trust architecture with Chrome Enterprise. This powerful combination brings the power of Zscaler Private Access™ (ZPA) enabling zero trust secure access to private applications to anyone across different locations and d...
VPN Risk Report Finds More Than Half of Organizations Experienced a VPN-related Cyberattack in the Last Year Zscaler ThreatLabz 2024 annual report reveals 78% of organizations plan to implement a Zero Trust strategy in the next 12 months in response to increasing exploits VPN security concerns rise as 91% of respondents express concerns about VPNs leading to a compromising breachThe survey identifies the top threats exploiting VPN vulnerabilities to be ransomware (42%), other types of malware (35%), and DDoS attacks (30%)Lateral movement is a top concern, as reported by a majority of ente...
TORONTO--(BUSINESS WIRE)-- Real Matters Inc. (TSX: REAL) (“Real Matters” or the “Company”), a leading network management services platform for the mortgage and insurance industries, today announced its financial results for the second quarter ended March 31, 2024. “We were very pleased to report positive consolidated Adjusted EBITDA(A) of $0.7 million and net income of $2.1 million in the second quarter as we outperformed the market on a sequential and year-over-year basis in U.S. Appraisal principally due to market share gains,” said Real Matters Chief Executive Officer Brian Lang. “Consoli...
TORONTO--(BUSINESS WIRE)-- Real Matters Inc. (“Real Matters” or the “Company”), a leading network management services provider for the mortgage lending and insurance industries, today announced that Lisa Melchior will be stepping down after serving on the Real Matters Board since 2017. The Company also announced the appointment of Kay Brekken to its Board of Directors. Ms. Brekken will succeed Ms. Melchior as a member of the Compensation, Nomination and Governance Committee. The changes are effective May 7, 2024. This press release features multimedia. View the full release here: Kay Brekken ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.